Although PKD is broadly expressed and involved in numerous cellular processes, its function in osteoclasts has not been previously reported. In this study, we found that PKD2 is the main PKD isoform expressed in osteoclastic cells. PKD phosphorylation, indicative of the activated state, increased after 2-3 days of treatment of bone marrow macrophages with M-CSF and RANKL, corresponding to the onset of preosteoclast fusion. RNAi against PKD2 and treatment with the PKD inhibitor CID755673 showed that PKD activity is dispensable for induction of bone marrow macrophages into tartrate-resistant acid phosphatase-positive preosteoclasts in culture but is required for the transition from mononucleated preosteoclasts to multinucleated osteoclasts. Loss of PKD activity reduced expression of DC-STAMP in RANKL-stimulated cultures. Overexpression of DC-STAMP was sufficient to rescue treatment with CID755673 and restore fusion into multinucleated osteoclasts. From these data, we conclude that PKD activity promotes differentiation of osteoclast progenitors through increased expression of DC-STAMP. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
CITATION STYLE
Mansky, K. C., Jensen, E. D., Davidova, J., Yamamoto, M., & Gopalakrishnan, R. (2013). Protein kinase D promotes in vitro osteoclast differentiation and fusion. Journal of Biological Chemistry, 288(14), 9826–9834. https://doi.org/10.1074/jbc.M112.444133
Mendeley helps you to discover research relevant for your work.